دورية أكاديمية
Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental Research.
| العنوان: | Driving the Way to Tuberculosis Elimination: The Essential Role of Fundamental Research. |
|---|---|
| المؤلفون: | Lienhardt C; Global Tuberculosis Programme, World Health Organization, Geneva, Switzerland., Kraigsley AM; American Association for the Advancement of Science, Washington D.C. National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland., Sizemore CF; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland. |
| المصدر: | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2016 Aug 01; Vol. 63 (3), pp. 370-5. Date of Electronic Publication: 2016 Jun 05. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Jan. 2011- : Oxford : Oxford University Press Original Publication: Chicago, IL : The University of Chicago Press, c1992- |
| مواضيع طبية MeSH: | Disease Eradication* , Research* , Tuberculosis*/diagnosis , Tuberculosis*/prevention & control , Tuberculosis*/therapy, Global Health ; Humans ; World Health Organization |
| مستخلص: | Tuberculosis has impacted human health for millennia. The World Health Organization estimated that, in 2014, 9.6 million people developed tuberculosis and 1.5 million people died from the disease. In May 2014, the World Health Assembly endorsed the new "End TB Strategy" that presents a pathway to tuberculosis elimination. The strategy outlines 3 areas of emphasis, one of which is intensified research and innovation. In this article we highlight the essential role for fundamental tuberculosis research in the future of tuberculosis diagnostics, treatment, and prevention. To maximize the impact of fundamental research, we must foster collaboration among all stakeholders engaged in tuberculosis research and control to facilitate open dialogue to assure that critical gaps in outcome-oriented science are identified and addressed. We present here a framework for future discussions among scientists, physicians, research and development specialists, and public health managers for the reinforcement of national and international strategies toward tuberculosis elimination. (© The Author 2016. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail journals.permissions@oup.com.) |
| References: | Lancet. 2016 Jun 4;387(10035):2312-22. (PMID: 27017310) Immunol Rev. 2015 Mar;264(1):308-18. (PMID: 25703568) BMC Infect Dis. 2014 Jan 31;14:53. (PMID: 24484441) Trends Microbiol. 2009 May;17(5):183-8. (PMID: 19375916) Tuberculosis (Edinb). 2011 Jul;91(4):329-38. (PMID: 21478054) Immunol Rev. 2015 Mar;264(1):319-26. (PMID: 25703569) Int J Infect Dis. 2016 Jan;42:17-23. (PMID: 26546234) Antimicrob Agents Chemother. 2016 Jan 11;60(3):1177-82. (PMID: 26824941) Infect Genet Evol. 2016 Jun;40:8-16. (PMID: 26917365) J Clin Microbiol. 2003 Jan;41(1):359-67. (PMID: 12517873) N Engl J Med. 2010 Sep 9;363(11):1005-15. (PMID: 20825313) Trends Microbiol. 2011 Jul;19(7):307-14. (PMID: 21561773) N Engl J Med. 2016 Jan 21;374(3):276-7. (PMID: 26789876) J Infect Dis. 2012 May 15;205 Suppl 2:S241-9. (PMID: 22448022) PLoS Pathog. 2009 Oct;5(10):e1000600. (PMID: 19855821) Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S6-13. (PMID: 22441160) N Engl J Med. 2014 Oct 23;371(17):1588-98. (PMID: 25337748) Expert Rev Vaccines. 2015;14(12):1573-85. (PMID: 26517361) Int J Infect Dis. 2011 Aug;15(8):e510-3. (PMID: 21737332) Am J Respir Crit Care Med. 2016 Sep 1;194(5):621-30. (PMID: 26910495) Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130427. (PMID: 24821914) J Comp Pathol. 2014 Nov;151(4):291-308. (PMID: 25246179) Nat Med. 2015 Oct;21(10):1223-7. (PMID: 26343800) PLoS Med. 2011 Nov;8(11):e1001135. (PMID: 22140369) J Med Primatol. 2012 Jun;41(3):191-201. (PMID: 22429048) Clin Infect Dis. 2014 Feb;58(4):470-80. (PMID: 24336911) Tuberculosis (Edinb). 2011 Mar;91(2):155-72. (PMID: 21247804) N Engl J Med. 2014 Oct 23;371(17):1577-87. (PMID: 25196020) Nature. 2014 Mar 27;507(7493):401. (PMID: 24670725) PLoS One. 2013 Sep 23;8(9):e75245. (PMID: 24086479) Drug Discov Today. 2012 May;17(9-10):514-21. (PMID: 22198298) Trends Genet. 2013 Mar;29(3):160-9. (PMID: 23245857) BMC Med. 2016 Mar 23;14:37. (PMID: 27005907) N Engl J Med. 2014 Oct 23;371(17):1599-608. (PMID: 25337749) |
| معلومات مُعتمدة: | 001 International WHO_ World Health Organization |
| فهرسة مساهمة: | Keywords: biomedical; elimination; global health; research; tuberculosis |
| تواريخ الأحداث: | Date Created: 20160609 Date Completed: 20180314 Latest Revision: 20220129 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC5006221 |
| DOI: | 10.1093/cid/ciw250 |
| PMID: | 27270671 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1537-6591 |
|---|---|
| DOI: | 10.1093/cid/ciw250 |